DR. JOHN YU, M.D.
Medical Practice in Los Angeles, CA
License number
California G84283
Category
Medical Practice
Type
Neurological Surgery
Address
Address
8700 Beverly Blvd., Los Angeles, CA 90048
Phone
(310) 423-7900
(310) 423-0777 (Fax)
(310) 423-0777 (Fax)
Organization information
See more information about JOHN YU at bizstanding.comJohn Yu MD
8631 W 3 St, Los Angeles, CA 90048
Industry:
Neurosurgeon
Phone:
(310) 423-7900 (Phone)
John Sun Yu
Professional information
Dr. John S Yu, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Neurosurgery
Address:
Cedar Sinai Medical Center NSG
8631 W 3Rd St STE 800E, Los Angeles 90048
(310) 423-7900 (Phone)
8631 W 3Rd St STE 800E, Los Angeles 90048
(310) 423-7900 (Phone)
Procedures:
Craniotomy, Herniated Disc (Cervical), Herniated Disc-Neck and Back, Laminectomy
Conditions:
Brain Tumor, Brain Tumors & Skull Base Tumors, Herniated Disc (Cervical), Herniated Disc-Neck and Back, Laminectomy
Certifications:
Neurosurgery, 2013
Awards:
Healthgrades Honor Roll, Southern California Super Doctors, 2007-Prese, America's Top Doctors, 2005 to pr, America's Top Cancer Speicalists, 2005-Prese, Over 70 published works, Featured in news ABC 7 Vaccine may give brain cancer patients time, Feb 14th 2011.
Featured in news CBS Vaccine for brain tumor June 7th 2011
Languages:
English
Hospitals:
Cedar Sinai Medical Center NSG
8631 W 3Rd St STE 800E, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
8631 W 3Rd St STE 800E, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Philosophy:
Dr. Yu provides compassionate and comprehensive care to patients facing devastating brain tumors and other neurological disorders.
Education:
Medical School
Harvard Medical School
Graduated: 1990
Beth Israel Hospital
Graduated: 1991
Mass General Hospital
Graduated: 1997
Harvard Medical School
Graduated: 1990
Beth Israel Hospital
Graduated: 1991
Mass General Hospital
Graduated: 1997
Student At The University Of Montana - School Of Business Administration
Location:
Greater Los Angeles Area
Industry:
Computer Software
Education:
The University of Montana - School of Business Administration 1982 - 2010
John Sun Yu, Los Angeles CA
Specialties:
Internal Medicine, Neurology, Neurological Surgery, Plastic Surgery, Obstetrics & Gynecology, Surgery
Work:
Cedars-Sinai Medical Center
8631 W 3Rd St, Los Angeles, CA 90048
8631 W 3Rd St, Los Angeles, CA 90048
Education:
Harvard University(1990)
Account Exec At Taycor
Position:
Account Exec at Taycor
Location:
Greater Los Angeles Area
Industry:
Financial Services
Work:
Taycor
-
Account Exec
Education:
University of California, Berkeley 2001 - 2006
Use Of Cxcr4 Protein Expression On The Surface Of Stem Cells As A Marker For Tumor Tropic Potential
US Patent:
2011025, Oct 20, 2011
Filed:
Jun 17, 2011
Appl. No.:
13/163553
Inventors:
John S. Yu - Los Angeles CA, US
Moneeb Ehtesham - Nashville TN, US
Moneeb Ehtesham - Nashville TN, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
C12Q 1/02, G01N 33/53
US Classification:
435 721, 435 29
Abstract:
The present invention relates to tumor tropic stem cells, and particularly to neural stem cells, and their use as delivery vehicles for therapeutic gene products to neoplastic foci. The stem cells with tumor tropic potential are selected based on the stem cells exhibiting CXCR4 receptors or an affinity for the chemokine SDF-1. The stem cells may additionally exhibit markers characteristic of astrocytic progenitors. The stem cells may be administered as part of a treatment regimen including the chemokine SDF-1.
John Yu, Los Angeles CA - Lawyer
Address:
Law Office of John Yu
4801 Wilshire Blvd STE 255, Los Angeles 90010
(213) 819-5537
4801 Wilshire Blvd STE 255, Los Angeles 90010
(213) 819-5537
Licenses:
California - Active 2011
Education:
Abraham Lincoln University
Univ of California at Los Angeles
Univ of California at Los Angeles
John William Yu, Los Angeles CA - Lawyer
Address:
University of Southern California
1150 S Olive St STE 2500, Los Angeles 90015
1150 S Olive St STE 2500, Los Angeles 90015
Licenses:
California - Active 1996
Education:
University of California, Hastings College of the Law
University of California at Los Angeles School of Law
University of California at Los Angeles School of Law
Herpes Simplex Virus Type 1 (Hsv-1)-Derived Vector For Selectively Inhibiting Malignant Cells And For Expressing Desired Traits In Malignant And Non-Malignant Mammalian Cells
US Patent:
6838279, Jan 4, 2005
Filed:
Oct 29, 2001
Appl. No.:
10/046491
Inventors:
Steven L. Wechsler - Westlake Village CA, US
Anthony B. Nesburn - Malibu CA, US
John S. Yu - Los Angeles CA, US
Keith L. Black - Los Angeles CA, US
Anthony B. Nesburn - Malibu CA, US
John S. Yu - Los Angeles CA, US
Keith L. Black - Los Angeles CA, US
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
A61K 4800, C12N 1563, C12N 1587, C12N 500
US Classification:
4353201, 435325, 435455, 435456, 435 691, 514 44, 4241991
Abstract:
Disclosed is an HSV-1-derived vector containing a DNA having a functional LAT promoter, or operative fragment thereof, a deletion in both copies of the HSV-1 LAT gene, and a deletion in both copies of the HSV-1 ICP34. 5 gene. The HSV-1-derived vectors are non-neurovirulent and do not spontaneously reactivate from latency, and they optionally contain a functional HSV thymidine kinase gene, which can enhance the effectiveness against cancer of drug treatment with gancyclovir or acyclovir. Alternatively, the HSV-1-derived vectors contain at least one transcriptional unit of a LAT promoter sequence operatively linked to a nucleic acid encoding a preselected protein. In some embodiments, the preselected protein is a nucleotide sequence encoding a polypeptide toxic for cells expressing the vector, for example, human interferon-γ. Also, disclosed are kits for expressing in a mammalian cell a gene encoding a preselected protein, and mammalian cells containing the HSV-derived vectors.
Differentiation Of Brain Tissue
US Patent:
2006014, Jul 6, 2006
Filed:
Feb 28, 2006
Appl. No.:
11/364454
Inventors:
John Yu - Los Angeles CA, US
Peter Kabos - Los Angeles CA, US
Moneeb Ehtesham - Nashville TN, US
Peter Kabos - Los Angeles CA, US
Moneeb Ehtesham - Nashville TN, US
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C12N 5/08
US Classification:
435368000
Abstract:
A method is described for generating a clinically significant volume of neural progenitor cells from whole bone marrow. A mass of bone marrow cells may be grown in a culture supplemented with fibroblast growth factor-2 (FGF-2) and epidermal growth factor (EGF). Further methods of the present invention are directed to utilizing the neural progenitor cells cultured in this fashion in the treatment of various neuropathological conditions, and in targeting delivery of cells transfected with a particular gene to diseased or damaged tissue.
John Yu
Location:
Greater Los Angeles Area
Industry:
Automotive